B6.129-Sertad1tm1Srn/Cnbc

Status

Available to order

EMMA IDEM:06217
International strain nameB6.129-Sertad1tm1Srn/Cnbc
Alternative nameSertad1
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolSertad1tm1Srn,
Gene/Transgene symbolSertad1

Information from provider

ProviderManuel Serrano
Provider affiliationMolecular Oncology, CNIO (Spanish National Cancer Research Centre)
Genetic informationExon 2 was replaced with a neo cassette. The absence of transcript expression was confirmed by Northern blot analysis on ES cell extracts.
Phenotypic informationSei1 (Sertad1) null mice are viable, do not present overt pathologies, have a normal lifespan, and have a normal susceptibility to spontaneous and chemically-induced cancer. Sei1 is highly expressed in pancreatic islets compared to other tissues. Interestingly, Sei1-null mice present lower number of islets, decreased beta-cell area, impaired insulin secretion, and glucose intolerance.
Breeding historyThe Sei1 mouse line has been backcrossed more than 9 generations to C57BL/6J.
References
  • Normal proliferation and tumorigenesis but impaired pancreatic function in mice lacking the cell cycle regulator sei1.;Fernandez-Marcos Pablo J, Pantoja Cristina, Gonzalez-Rodriguez Agueda, Martin Nicholas, Flores Juana M, Valverde Angela M, Hara Eiji, Serrano Manuel, ;2010;PloS one;5;e8744; 20090907
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreCNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain
Animals used for archivinghomozygous C57BL/6J, wild-type C57BL/6J
Stage of embryos2-cell

Disease and phenotype information

MGI phenotypes (allele matching)
  • decreased insulin secretion / MGI
  • impaired glucose tolerance / MGI
  • decreased pancreatic beta cell mass / MGI
  • decreased pancreatic islet number / MGI
  • neoplasm / MGI
  • cellular phenotype / MGI
  • mortality/aging / MGI

Literature references

  • Normal proliferation and tumorigenesis but impaired pancreatic function in mice lacking the cell cycle regulator sei1.;Fernandez-Marcos Pablo J, Pantoja Cristina, Gonzalez-Rodriguez Agueda, Martin Nicholas, Flores Juana M, Valverde Angela M, Hara Eiji, Serrano Manuel, ;2010;PloS one;5;e8744; 20090907

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).